For IDH-wildtype GBM, a cutoff of ≥10% is usually used to define a “methylated” or “unmethylated” MGMT promoter according to the average methylation level, and a cutoff ≥30% is recommended to stratify a “weakly methylated” vs “methylated” promoters28,31. The gene discussed is MGMT; the disease is glioblastoma.